The Parvovirus-B19 DNA, Quantitative PCR test is a molecular diagnostic procedure used to measure the amount of Parvovirus-B19 DNA in patient samples. Parvovirus-B19 is associated with conditions such as erythema infectiosum (fifth disease), aplastic crisis in patients with hemolytic anemia, and complications in immunocompromised individuals or pregnant women. This test is performed to confirm infection, monitor viral load, and assess disease severity, helping clinicians make informed decisions about patient management and treatment strategies.
It helps diagnose Parvovirus-B19 infections, assess disease severity, and guide treatment, especially in immunocompromised patients, pregnant women, and those with blood disorders.
Patients with unexplained anemia, fetal complications, or suspected Parvovirus-B19 infection may be recommended for this test.
A positive result confirms Parvovirus-B19 infection and indicates viral load, guiding treatment and monitoring.
A negative result suggests no detectable Parvovirus-B19 DNA, but other causes of illness may need evaluation.
No, medications do not interfere with PCR detection of viral DNA.
Yes, it is safe and often used in pediatric patients with suspected Parvovirus-B19 infection.
Without testing, Parvovirus-B19 infections may be missed, leading to complications such as anemia or fetal loss.
...
Didn't recieved OTP Yet? Resend OTP